Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Research|November 17, 2006
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancerKarin G Hermans, Ronald van Marion, Herman van Dekken, et al.
Cancer Research|May 3, 2008
Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancerKarin G Hermans, Anke A Bressers, Hetty A van der Korput, et al.
Genes, Chromosomes & Cancer|January 21, 2004
Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell linesKarin G Hermans, Dirk C van Alewijk, Joris A Veltman, et al.
Cancer Cell|June 16, 2012
ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21Catherine A O'Brien, Antonija Kreso, Paul Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancerKarin G Hermans, Joost L Boormans, Delila Gasi, et al.
Blood Cancer Journal|January 17, 2019
Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1Daniel Ernst, Brent A Williams, Xing-Hua Wang, et al.
International Journal of Cancer|May 19, 2005
Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatmentRute B Marques, Sigrun Erkens-Schulze, Corrina M de Ridder, et al.
Cell Stem Cell|July 13, 2010
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewalMichael Milyavsky, Olga I Gan, Magan Trottier, et al.
European Urology|September 1, 2009
Expression of the androgen-regulated fusion gene TMPRSS2-ERG does not predict response to endocrine treatment in hormone-naïve, node-positive prostate cancerJoost L Boormans, Karin G Hermans, Angelique C J Ziel-van der Made, et al.
Transplantation and Cellular Therapy|December 26, 2024
Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS TrialEnass H Raffa, Taylor M Harris, Chane Choed-Amphai, et al.
Pageof 2